Physician profile
Kendra Owen
NPI 1073123915
$1,027.33
in general payments reported to CMS, 2019-2025
16 companies · $68.43 in 2025
The $68.43 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $601 · 2022: $55.29 · 2024: $302 · 2025: $68.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $181.91 | 2024 | Amplatzer Amulet |
| Amarin Pharma, INC. | $138.40 | 2021 | |
| Esperion Therapeutics, INC. | $121.15 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.18 | 2021-2022 | |
| Amgen INC. | $100.20 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $96.60 | 2021-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $77.15 | 2021 | |
| Janssen Pharmaceuticals, INC | $40.13 | 2024 | Xarelto |
| Abiomed | $28.66 | 2024 | Impella |
| Novo Nordisk INC | $23.51 | 2025 | Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $22.34 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.16 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.21 | 2021 | |
| Scpharmaceuticals INC. | $16.14 | 2025 | |
| Medtronic, INC. | $15.50 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.